Day-to-day variability of voltage measurements used in electrocardiographic criteria for left ventricular hypertrophy  by Farb, Andrew et al.
618 JACC Vol. 15, No. 3 
March 1, 1990:618-23 
Day-to-Day Variability of Voltage Measurements Used in 
Electrocardiographic Criteria for Left Ventricular Hypertrophy 
ANDREW FARB, MD, RICHARD B. DEVEREUX, MD, FACC, PAUL KLIGFIELD, MD, FACC 
New York, New York 
Although electrocardiographic (ECG) voltage can be used 
to estimate left ventricular mass, day-to-day variability of 
voltage combinations used for this purpose must be estab- 
lished before ECG changes are taken as evidence of pro- 
gression or regression of hypertrophy. Accordingly, serial 
ECGs (mean 8 days apart), derived from 10 s samples 
digitized at 250 Hz, were examined in 78 patients with no 
intercurrent change in clinical status. The coefficient of 
variation was calculated as 1 SD of the difference between 
paired voltage measurements, divided by the average mean 
value. 
Coefficient of variation for single leads was 22.3% for 
Svr, 27.0% for Rv, or Rv6, 27.1% for RavL and 34.7% for 
Sv3. Coefficient of variation was lower for voltage combi- 
nations than for individual lead measurements: 18.5% for 
Sokolow-Lyon voltage (Sv, + Rv, or R,,), 22.3% for 
Left ventricular hypertrophy is associated with high cardio- 
vascular risk in hypertensive patients and in the general 
population (1,2), but detection of hypertrophy and serial 
estimation of changes in left ventricular mass remain impor- 
tant diagnostic problems (3). Traditional electrocardio- 
graphic (ECG) criteria that are based on combined voltage 
partition values have poor sensitivity for left ventricular 
hypertrophy (4), and generally fail to identify patients with 
mild to moderate increases in ventricular mass (5,6). Al- 
though echocardiography can accurately measure left ven- 
tricular mass and has been used to predict cardiovascular 
risk in selected groups of patients (1,2), its use in large 
epidemiologic surveys is limited by cost and availability, as 
well as by occasional technical failure (7). 
Combinations of ECG voltage and duration criteria that 
correlate as continuous variables with left ventricular mass 
have been proposed as practical methods for longitudinal 
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Gubner-Ungerleider voltage (R, t S,) and 24.8% for 
Cornell voltage (R,,, t S,,). Serial reclassification due 
to variation above and below standard criteria for left 
ventricular hypertrophy occurred in only 3% of patients 
for Sokolow-Lyon voltage and 4% of patients for Cornell 
voltage in this group. Minute to minute reproducibility 
of voltage was assessed with electrodes in place in a sepa- 
rate group of 26 patients, and the coefficient of variation 
was 2.6% for Sokolow-Lyon voltage, 5.9% for Gubner- 
Ungerleider voltage and 2.9% for Cornell voltage. 
These data indicate that serial variability of computer- 
measured ECG voltage combinations is high, due primarily 
to changes in lead placement and body position, but less 
than the variability of computer-measured voltage in indi- 
vidual leads. 
(J Am Co11 Cardiol1990;15:618-23) 
evaluation of progression and regression of ventricular hy- 
pertrophy (8,9), and changing voltage has served as a marker 
for changing ventricular mass in previous studies (10-12). 
However, serial differences in voltage may reflect not only 
changes in generated signal amplitude and variations in 
performance among machines, but also the confounding 
effects of high frequency filtration and digital sampling error 
(13,14), variable lung and torso impedance (15) and, occa- 
sionally, large changes in patient position, the position of the 
heart in the chest and electrode location (16-19). As ECG 
methods for the assessment of left ventricular mass are 
utilized in epidemiologic studies and applied to serial com- 
parison of tracings in clinical practice, the day-to-day vari- 
ability of recorded ECG voltages must be established before 
changes in amplitude can be accepted as evidence for 
progression or regression of hypertrophy. 
Therefore, the purpose of this study was to quantify the 
day-to-day variability of combined ECG voltages that have 
been correlated with left ventricular mass in patients without 
active cardiopulmonary disease. This analysis yields insights 
into sources of voltage variation between serial ECGs that 
bear on routine test interpretation and epidemiologic studies 
of ventricular hypertrophy. 
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Methods 
Study group. Consecutive ECGs from adult medical and 
surgical patients at The New York Hospital-Cornell Medical 
Center were selected for initial screening if the tracings 
fulfilled the following requirements: (I) two consecutive, 
technically satisfactory ECGs in nonpaced rhythm were 
obtained within 60 days of each other; (2) the ECGs were 
performed on a routine (nonemergency) basis; and (3) nor- 
mal sinus rhythm without atria1 or ventricular premature 
complexes was present. Patients were excluded if a chart 
review revealed evidence of active cardiac disease (such as 
ischemia or congestive heart failure), significant metabolic 
abnormalities or recent thoracic surgery. No attempt was 
made to specifically include or exclude patients on the basis 
of ECG evidence for left ventricular hypertrophy. 
Serial measurements for analysis of day-to-day variabil- 
ity of combined voltage criteria were made from 78 pairs of 
ECGs (39 from men and 39 from women) separated by a 
mean interval of 8 days. The mean age of the study group 
was 59 years. After analysis of the data was complete, it was 
noted that two pairs of ECGs were from separate intervals in 
the same woman; accordingly, the 39 paired measurements 
in women represent data from 38 patients. 
Serial measurements for analysis of immediate variability 
of combined voltage criteria were also made from an addi- 
tional 26 paired ECGs in a separate group of clinically stable 
patients, including 14 men and 12 women, whose mean age 
was 58 years. These ECGs were taken within 1 min of each 
other for the purpose of this part of the study, without 
removing the recording electrodes or changing patient posi- 
tion between tracings. All of these patients also had normal 
sinus rhythm, and were also selected without regard to the 
magnitude of ECG voltage. 
Electrocardiography. All ECGs were acquired by labora- 
tory technicians using Marquette Electronics, Inc. MAC-2 
carts and a MUSE central system, from which computer- 
based measurements were derived from the median com- 
plexes formed by IO s sampling of 12 simultaneous leads 
digitized at 2.50 Hz. Median complexes are formed from the 
median voltage measured by computer for each 4 ms of 
digitally sampled data from successive complexes analyzed 
during the IO s recording interval. Amplitudes are reported 
in microvolts (FV), and in each case, visual confirmation of 
the measurement was performed by comparison with the 
raw ECG tracing. 
Combined voltage criteria were derived by addition of 
computer-measured amplitudes, according to the following 
definitions: I) Sokolow-Lyon voltage: S,, + the greater of 
Rv, or Rv, (20); 2) the limb lead voltage of Gubner and 
Ungerleider: R, + S, (21); and 3) Cornell voltage: R,vt< + 
Sv, (22). Paired measurements were also examined for 
computer-derived heart rate and QRS width (in ms). both of 
which were also subject to visual confirmation. 
The paired studies used for evaluation of day-to-day 
variability were all done as clinically indicated, routine 
tracings, and all were selected randomly and retrospectively 
for screening, as outlined. Accordingly, technicians were not 
aware that these tracings were to be compared, there was no 
attempt to provide the same technician for each study and no 
marking of previous electrode placement was used. All 
paired studies used for evaluation of immediate reproduc- 
ibility of ECG measurements were performed by a single 
technician who was aware of the purpose of the sequential 
recordings. 
Statistical methods. Variability of serial measurements 
was expressed according to several methods. The coefficient 
of variability, in percent, was taken as the standard deviation 
(SD) of the difference between paired measurements divided 
by the average value of the means for each set of serial 
measurements. In addition, the coefficient of reproducibility, 
in PV. was calculated as 2 SD of the difference between 
paired measurements. 
Each term provides different, but related, information. 
The coefficient of variability estimates 1 SD of variation as a 
percent of the measurement of interest, and it is, therefore, 
dependent in part on the magnitude of the underlying 
measurement. The coefficient of reproducibility estimates 
95% confidence limits for the variability of voltage in abso- 
lute measurement units, taken as 2 SD of variation (rather 
than the I SD used in the numerator of the coefficient of 
variability). As a result of differences in magnitude for the 
various voltages that were examined, the coefficient of 
variability may be proportionally larger or smaller than 
would be suggested by the coefficient of reproducibility 
alone. 
For each pair of measurements, the standard coefficient 
of correlation (r) derived from linear regression analysis was 
also calculated, despite its recognized limitations (23); the 
standard error of the estimate is equivalent to one half of the 
coefficient of reproducibility. 
Results 
Day-to-day variability of ECG voltage. Day-to-day vari- 
ability of individual ECG voltage measurements and com- 
bined voltage criteria for left ventricular hypertrophy are 
described by the coefficients of reproducibility and coeffi- 
cients of variability in Table 1. Coefficients of variability for 
amplitude measurements in individual leads ranged from 
18% for R, to 39% for S,, and day-to-day variability for each 
of the combined voltage criteria for left ventricular hyper- 
trophy was also large (18.5% for Sokolow-Lyon voltage, 
22.3% for Gubner-Ungerleider voltage, and 24.8% for Cor- 
nell voltage). In each case, the coefficient of variability of 
combined voltage was smaller than the variability in compo- 
nent single leads. Day-to-day variability of individual lead 
and combined voltages was similar when men and women 
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Table 1. Day-to-Day Variability of ECG Voltage Measurement in Table 3. Effect of Voltage Magnitude on Reproducibility 
78 Patients and Variability 
Coefficient Average Coefficient of Coefficient of 
Correlation Value Reproducibility Variability 
Measurement (r) (PV) (PV) (%) 
S VI 0.892 994 443 22.3 
R vs or 6 0.884 1,569 846 27.0 
SLV 0.911 2,562 945 18.5 
R, 0.884 838 307 18.3 
S, 0.934 351 274 39.0 
R,S, 0.909 1,189 530 22.3 
R i3VL 0.905 538 292 27.1 
s 
C”v’ 
0.846 958 665 34.7 
0.863 1,496 743 24.8 
CV = Cornell voltage (sum of R,,, plus S,,); BCG = electrocardio- 
graphic; R, = R amplitude in standard lead I; R,S, = Gubner-Ungerleider 
voltage (sum of R, plus S,); R,,, = R amplitude in standard lead aVL; 
R v5 0r6 = R amplitude in V, or V,, whichever is larger; SLV = Sokolow-Lyon 
voltage (sum of S,, plus R vs or .J; S, = S amplitude in lead III; Sv, = S 
amplitude in lead Vl; Sv, = S amplitude in lead V3. 
were examined separately (Table 2). For the entire group, 
the day-to-day variability of measured heart rate was 15.9% 
(coefficient of reproducibility 26 beatslmin), and variability 
for QRS duration was 5.6% (coefficient of reproducibility 10 
ms). 
The relation of the coeficients of variability and repro- 
ducibility to the absolute magnitude of measured voltage 
was further explored by calculation of these coefficients for 
subsets of patients partitioned at the mean values of 
Sokolow-Lyon voltage and Cornell voltage within the total 
population (Table 3). Variability of Sokolow-Lyon voltage 
increased with higher voltage (>2,600 pV, the population 
mean value). In contrast, the coefficient of reproducibility of 
Cornell voltage was less dependent on the absolute magni- 
Table 2. Reproducibility and Variability of ECG Voltage 
Measurement, According to Gender in 78 Patients 
Measurement 
Coefficient of 
Reproducibility 
(PV) 
Men Women 
(n = 39) (n = 39) 
Coefficient of 
Variability 
(%) 
Men Women 
(n = 39) (n = 39) 
S VI 377 505 
R vs or 6 895 776 
SLV 1,026 846 
R, 276 336 
S, 233 312 
R,S, 446 606 
R GtVL 253 325 
C”; S 703 18 752 618
Definitions and abbreviations as in Table 1. 
21.2 22.3 
27.2 26.0 
20.2 16.3 
17.9 18.6 
37.9 39.5 
20.1 23.3 
25.4 28.1 
24.1 35 4 25.0 33 5
Measurement 
Coefficient of Coefficient of 
Reproducibility Variability 
(PV) (%) 
SLV <2,6Ofl FV 563 14.4 
SLV >2,6Nl pv 1,373 19.2 
cv Cl,500 pv 619 28.0 
cv > 1,500 /Jv 810 19.7 
Definitions and abbreviations as in Table 1. 
tude of combined voltage, so that percent variability was 
actually less at higher (>1,500 pV) than at lower measured 
amplitudes. 
Serial reclassification. Despite the large day-to-day vari- 
ability of combined voltage measurements, diagnostic re- 
classification of individual patients between studies because 
of voltage variation above and below established partition- 
based criteria for left ventricular hypertrophy was uncom- 
mon in this population. Only 2 (3%) of 78 patients fulfilled 
Sokolow-Lyon criteria (>3,500 PV [3.5 mV]) and only 3 
(4%) fulfilled gender-adjusted Cornell voltage criteria 
(>2,800 PV for men, >2,000 PV for women) for hypertrophy 
on one, but not the other, of the paired studies. This may be 
a consequence of the wide range of normal voltages and the 
smaller number of higher voltages present in our patients. 
Only 10 patients had Sokolow-Lyon voltage and only 28 
patients had Cornell voltage that was within 500 PV (20.5 
mV) of the amplitudes routinely used for the diagnosis of 
hypertrophy. 
Immediate variability of ECG voltage. Immediate vari- 
ability of individual and combined voltages, with electrodes 
in place, is shown in Table 4. Minute to minute coefficients 
of variability for individual amplitudes ranged from 4.3% for 
S,, to 9.0% for S,, and variability of each combined voltage 
criterion was lower than that of its component parts (2.6% 
Table 4. Immediate Reproducibility of ECG Voltage Measurement 
in 26 Patients 
Coefficient of Average Coefficient of Coefficient of 
Correlation Value Reproducibility Variability 
Measurement (r) (PV) (PV) (%) 
S VI 
R “5‘x6 
SLV 
R, 
S, 
R,S, 
R CXVL 
S 
C”v’ 
0.994 934 
0.994 1,416 
0.997 2,350 
0.992 715 
0.997 370 
0.996 1,084 
0.995 471 
0.999 984 
0.998 1.461 
80 4.3 
144 5.1 
124 2.6 
71 4.9 
66 9.0 
127 5.9 
78 8.2 
90 4.5 
128 2.9 
Definitions and abbreviations as in Table 1 
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for Sokolow-Lyon voltage, 2.9% for Cornell voltage and 
5.9% for Gubner-Ungerleider voltage). Immediate variability 
of heart rate was 3.8% (coefficient of reproducibility 6 
beats/min), and variability for QRS duration was 4.7% 
(coefficient of reproducibility 8 ms). 
Discussion 
These data demonstrate large day-to-day variability of 
single and combined ECG voltages in a group of hospitalized 
patients in stable condition. With respect to intraindividual 
variability of single leads, our findings are similar in magni- 
tude to previously reported data (17,24,25), but also demon- 
strate and quantify the variability of more clinically relevant 
combined lead voltages used as criteria for the detection of 
left ventricular hypertrophy and for the estimation of left 
ventricular mass (20-22). 
Variability of individual voltage measurements was sub- 
stantially reduced when serial tracings were taken without 
removing the recording electrodes and without changing 
patient position, as also noted in previous studies (17,24-26) 
in which electrodes were left in place between tracings or 
specific attention was paid to constant lead placement by 
marking of the skin. However, this method of assuring 
reproducibility of electrode location is not practical in stud- 
ies examining serial changes that occur over periods of 
months to years, and cannot be assumed in retrospective 
analysis of established data bases. 
Previous studies. Few data are available regarding the 
effect of day-to-day measurement variability on the diagnos- 
tic performance of commonly used voltage criteria for left 
ventricular hypertrophy. Larkin and Hunyor (26) measured 
intertest variability of combined precordial voltage deter- 
mined by the sum of the largest individual R and S waves in 
a small group of normal subjects over 4 consecutive days. 
When electrodes were removed between recordings, the 
coefficient of variation (estimated from their data according 
to our methods) was approximately 12%, with a coefficient 
of reproducibility of approximately 720 pV. These values 
are comparable with our findings for more widely used 
voltage combinations. In the Multiple Risk Factor Inter- 
vention Trial (27), only 2% of patients had a significant 
worsening of Minnesota code criteria for left ventricular 
hypertrophy between serial ECGs taken 2 weeks apart. This 
inter-test reclassification rate is similar to the findings in our 
patients. 
Sources of QRS voltage variability. Serial differences in 
voltage may be caused by biologic, temporal or measure- 
ment variability. Sources of variation include a true change 
in generated signal amplitude, which, in addition to changing 
cardiac mass or geometry, might also reflect changing met- 
abolic conditions on a beat-to-beat or minute-to-minute 
basis. Variability of measured voltage might also result from 
changing transthoracic impedance due to effects of respira- 
tion (15) torso geometry (28) or electrode conductivity. 
Most important, variability can reflect changes in relative 
cardiac orientation within the chest due to altered body 
position or different phase of respiration during recording, 
or, of course, to a change in electrode placement between 
tracings. 
In addition to simple measurement error and the error due 
to differences among recording units, variability of ampli- 
tude determination in digitally acquired ECGs can result 
from sampling error that is inherent to the digitizing process 
itself (13). When ECG waveforms are sampled every 4 ms, it 
may be difficult to accurately quantify high frequency am- 
plitudes that can peak between samples; however, compa- 
rable error in amplitude measurement can also affect analog 
ECG signals when standard high frequency filtration is used 
(14). Although the digital sampling problem may be mini- 
mized by signal processing that can effectively average 
acquired data during generation of a median complex, the 
potential error involved in digital-based measurement of R 
wave amplitude has been estimated by Zywietz (13) to 
approximately 5% to 10% for adult tracings sampled at 250 
Hz. 
Immediate and day-to-day variability of voltage. If it is 
assumed that computer measurement error is negligible, 
the relatively small changes in minute to minute voltage 
found when serial tracings were obtained with electrodes in 
place should represent variability due to the combined 
effects of digital sampling error and phasic respiration. 
In each case, the coefficient of variability for combined 
voltage criteria was less than the variability in component 
single leads. This is most likely explained by the some- 
what orthogonal orientation of leads from which combined 
voltages are derived, which may partially offset the effect 
of respiration on amplitude variation in any one lead with 
an opposite variation in the second. The data of Table 4 
suggest that voltage variability due to digital sampling 
error under our recording conditions is unlikely to exceed 
2% to 3%, whereas variability in individual leads due to 
respiration under these conditions approximates 5% to 
9%. It is likely that variability due to phasic change in 
respiration is also minimized by our recording methods 
because measurements were made from signal-averaged 
median complexes obtained during 10 s of data acquisition 
in each lead. 
Smaller variability for combined voltages than for indi- 
vidual lead voltages was also found in our day-to-day 
studies. The greater magnitude of day-to-day than of imme- 
diate variability in our patients is most reasonably explained 
by the additional combined effects of inconstant patient 
position and electrode placement. This variability was sim- 
ilar in men and women, a finding also noted by Michaels and 
Cadoret (25). The separate effects of patient position and 
variable electrode placement might have been distinguished 
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by marking lead locations in a subset of subjects studied on 
different days. This was not examined in the present study 
group which, instead, can be considered to be representative 
of patients receiving routine serial ECG evaluation with all 
technical inconsistencies preserved (27). 
Clinical implications. The large day-to-day variability of 
commonly used voltage criteria for left ventricular hypertro- 
phy suggests that these measurements alone may be poor 
markers for modest progression and regression of left ven- 
tricular mass. By way of example, examination of Table 1 
reveals that repeat measurements of Sokolow-Lyon voltage 
(Sv, + R,, or Rv,) can differ by as much as +-37% of the 
original amplitude, with a corresponding difference in abso- 
lute voltage as much as +945 pV, before the change exceeds 
95% of the variability found in routine day-to-day examina- 
tion of subjects in stable condition. Similarly, serial mea- 
surements of Cornell voltage (R,,, + S,,) may differ by as 
much as +50% before the change exceeds 95% of expected 
variability, with the smaller corresponding difference in 
absolute voltage of 2743 PV explained by the smaller mean 
amplitude for this combined criterion. Thus, changes of 
combined voltage that occur within these limits may repre- 
sent measurement variability and not a clinically relevant 
difference in ventricular structure. 
In addition, ourjindings bear directly on the interpreta- 
tion of standard ECG criteria for left ventricular hypertrophy 
and have particular relevance to the serial comparison of 
tracings. For example, with reference to Sokolow-Lyon 
voltage, it is clear that combined precordial measurements of 
33 mm (3.3 mV) and 40 mm during serial studies are entirely 
within the expected range of day-to-day variability predicted 
by our data. Yet one tracing would be considered normal, 
although the other might be interpreted as indicative of left 
ventricular hypertrophy. More important, literal comparison 
of the two tracings presents the suggestion that ventricular 
hypertrophy has developed between examinations, or in the 
equally likely reverse sequence, that it has resolved. These 
conclusions are not justified by our findings, which, instead, 
argue for incorporating the range of expected measurement 
variability in both single and comparative diagnostic state- 
ments. 
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